IMUGENE LIMITED - Capital/Financing Update 2025

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

IMUGENE LIMITED

Announcement Type

New announcement

Date of this announcement

Tuesday September 02, 2025

The +securities to be quoted are: Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

5,501,568 Quoted Options Expiring 30 March 2026 EX $0.43 have been issued to SPP participants, as detailed in the Appendix 3B dated 12 August 2025 and consistent with the Appendix 2A dated 1 September 2025.

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
IMUO	OPTION EXPIRING 30-MAR-2026	5,501,568	01/09/2025

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

IMUGENE LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ABN

Registration number

99009179551

1.3 ASX issuer code

IMU

1.4 The announcement is

New announcement

1.5 Date of this announcement

2/9/2025

Appendix 2A - Application for quotation of securities

2 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS?

Yes

2.3c.1 Date of +disclosure document or +PDS?

16/8/2025

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

Appendix 2A - Application for quotation of securities

3 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Additional +securities to be quoted in an existing class ASX +security code and description IMUO : OPTION EXPIRING 30-MAR-2026

Issue date 1/9/2025 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details

Number of +securities to be quoted 5,501,568 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities Options issued under the Share Purchase Plan, as announced on 16 July 2025. Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.280000 Any other information the entity wishes to provide about the +securities to be quoted

The purpose(s) for which the entity is issuing the securities

To raise additional working capital

Appendix 2A - Application for quotation of securities

4 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

==> picture [540 x 710] intentionally omitted <==

Appendix 2A - Application for quotation of securities

5 / 8

Appendix 2A - Application for quotation of securities

Part 4 - Issued capital following quotation

==> picture [21 x 22] intentionally omitted <==

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

+securities subject of this application)
	Total number of
ASX +security code and description	+securities on issue
IMU : ORDINARY FULLY PAID	295,832,944
IMUOE : OPTION EXPIRING 31-AUG-2026	21,698,915
IMUO : OPTION EXPIRING 30-MAR-2026	56,679,180

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
IMUAAJ : OPTION EXPIRING 18-SEP-2026 EX $6.392	113,971
IMUAAK : OPTION EXPIRING 30-SEP-2026 EX $8.16	392,154
IMUAAF : OPTION EXPIRING 31-MAR-2026 EX $11.22	5,882,353
IMUAAD : OPTION EXPIRING 30-JUN-2026 EX $6.12	44,118
IMUAAE : OPTION EXPIRING 01-JUL-2026 EX $6.392	45,294
IMUAAL : OPTION EXPIRING 03-JAN-2027 EX $4.828	15,016
IMUAAM : OPTION EXPIRING 09-JAN-2027 EX $5.236	17,779
IMUAAG : OPTION EXPIRING 30-JUN-2026 EX $10.404	1,094,580
IMUAAH : OPTION EXPIRING 29-SEP-2026 EX $6.256	50,001
IMUAAI : OPTION EXPIRING 14-DEC-2026 EX $13.60	88,235
IMUAAA : OPTION EXPIRING 01-FEB-2026 EX $13.60	29,412
IMUAAN : RESTRICTED STOCK UNITS	4,932,399

Appendix 2A - Application for quotation of securities

6 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Appendix 2A - Application for quotation of securities
IMUAAO : PERFORMANCE RIGHTS AWARD	1,114,949
IMUAAP : OPTION EXPIRING 13-SEP-2028 EX $2.278	333,335
IMUAAQ : OPTION EXPIRING 13-SEP-2028 EX $3.094	352,942
IMUAAR : CONVERTIBLE NOTES	200
IMUAAS : WARRANTS EXPIRING 24-JAN-2030 EX $0.33	15,479,877

Appendix 2A - Application for quotation of securities

7 / 8

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No

5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? Yes

5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1

20/8/2025

Appendix 2A - Application for quotation of securities

8 / 8

AI assistant

IMUGENE LIMITED Capital/Financing Update 2025

65124_rns_2025-09-01_7feae35b-d94a-4c94-852c-a8041e53ee5a.pdf

Entity name

Announcement Type

Date of this announcement

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

Total number of +securities to be quoted

1.1 Name of entity

1.2 Registered number type

1.3 ASX issuer code

1.4 The announcement is

2.1 The +securities to be quoted are:

2.2 The +class of +securities to be quoted is:

2.3c Have these +securities been offered under a +disclosure document or +PDS?

2.3c.1 Date of +disclosure document or +PDS?

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

AI assistant

IMUGENE LIMITED — Capital/Financing Update 2025

65124_rns_2025-09-01_7feae35b-d94a-4c94-852c-a8041e53ee5a.pdf

Entity name

Announcement Type

Date of this announcement

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

Total number of +securities to be quoted

1.1 Name of entity

1.2 Registered number type

1.3 ASX issuer code

1.4 The announcement is

2.1 The +securities to be quoted are:

2.2 The +class of +securities to be quoted is:

2.3c Have these +securities been offered under a +disclosure document or +PDS?

2.3c.1 Date of +disclosure document or +PDS?

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

More from IMUGENE LIMITED

IMUGENE LIMITED Capital/Financing Update 2025